Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Focus Medical Herbs is one of the original licensed producers of medical cannabis in Israel, now operating primarily as an importer and distributor, supplying premium, internationally-sourced cannabis (Canada, Spain, Israel) for Israeli patients via exclusive agreements with IM Cannabis (IMC brand). Their own cultivation facility was closed in June 2022, but import and distribution operations continue unaffected and consistently supply Israeli pharmacies. Estimated revenues from pharmacy supply agreements were $193.5 million over three years with about 33,075 kg contracted.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Focus Medical Herbs.